Historial de carrera de Lynn Gallant
Antiguos cargos conocidos de Lynn Gallant.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 22/02/2023 | 01/05/2023 |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Director Técnico/Científico/I+D | - | - |
Formación de Lynn Gallant.
| University of New England | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Canadá | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Lynn Gallant
- Experiencia
